PHM1 COST-EFFECTIVENESS OF ONCE-DAILY ORAL CHELATION THERAPY WITH DEFERASIROX VERSUS INFUSIONAL DEFEROXAMINE IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS

May 1, 2006, 00:00 AM
10.1016/S1098-3015(10)64747-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)64747-X/fulltext
Section Title :
Section Order : 163
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64747-X&doi=10.1016/S1098-3015(10)64747-X
HEOR Topics :
Tags :
Regions :